Disease/Infection News

RSS

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

Researchers compared the levels of cross-reactive neutralizing antibodies elicited by SARS-CoV-2 Omicron BA.4 and BA.1 infections.

20 Jul 2022

What is the association between natural killer cell dysfunction and COVID-19 disease severity?

Researchers assessed the association between natural killer cell dysfunction and COVID-19 disease severity.

20 Jul 2022

Researchers describe viral shedding of monkeypox virus in patients to better understand the possible role of different bodily fluids in disease transmission

Researchers described the shedding of the monkeypox (MPX) virus (MPXV) in Barcelona city of Spain.

20 Jul 2022

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

Yale scientists have developed a novel Omicron-specific mRNA vaccine that offers superior immune protection against two viral subvariants than standard mRNA vaccines.

20 Jul 2022

Adolescents are more likely than older adults to get COVID

At the beginning of the pandemic, there was a general perception that children and teenagers were much less likely to get COVID-19 than adults. It was fueled by early data from across the globe that found very low rates of COVID in adolescents (defined as ages 10-19) and youth (15-24). But the data was mixed and some questioned its validity.

20 Jul 2022

Influenza surveillance systems may have helped detect early signs of COVID-19 pandemic

Outliers in the number of cases of influenza-like illness (ILI) that tested negative for influenza were present in global influenza surveillance networks early in the COVID-19 pandemic, an average of 13.3 weeks before the first reported COVID-19 peaks in 16 of the 28 countries included in a new study publishing July 19th in PLOS Medicine by Natalie Cobb of University of Washington, US, and colleagues.

20 Jul 2022

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes, particularly in the three months following infection, according to a new study by Emma Rezel-Potts, Martin Gulliford, and colleagues of King's College London, United Kingdom, publishing July 19th in the open access journal PLOS Medicine.

20 Jul 2022

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

Malaria is the deadliest mosquito-borne parasitic infection of humans. In 2021, after a century of research, the World Health Organization (WHO) approved the world's first malaria vaccine.

20 Jul 2022

Skins swabs may help identify Covid-19 infection in the future

Skin swabs are "surprisingly effective" at identifying Covid-19 infection, according to new research from the University of Surrey, offering a route to a non-invasive future for Covid-19 testing.

19 Jul 2022

New vaccine shows promise to fight Lassa virus

Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever.

19 Jul 2022

CDC experts update on monkeypox in the United States

Scientists working with the CDC provide the latest information about monkeypox in the U.S.

19 Jul 2022

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data.

19 Jul 2022

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

A recent study discusses the use of commensal bacteria in the gut and/or respiratory tract to deliver viral antigens to the host, thus acting as vaccines

19 Jul 2022

Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome

A new study has pointed out that Molnupiravir treatment increases the ratio of transition to transversion mutations in COVID-19 patients and that the treatment does not appear to induce resistance mutations in the SARS-CoV-2 genome.

19 Jul 2022

Study shows how a critical Lassa virus protein drives infection

Lassa fever is a viral illness that is far too common in West Africa. Although it can have a mortality rate of 15 percent in severe cases, up to 90% in pregnant women, and causes deafness in a quarter of survivors, there is no vaccine or antiviral to protect against Lassa virus.

19 Jul 2022

Disease/Infection News

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

What is the association between natural killer cell dysfunction and COVID-19 disease severity?

Researchers describe viral shedding of monkeypox virus in patients to better understand the possible role of different bodily fluids in disease transmission

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

Adolescents are more likely than older adults to get COVID

Influenza surveillance systems may have helped detect early signs of COVID-19 pandemic

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

Skins swabs may help identify Covid-19 infection in the future

New vaccine shows promise to fight Lassa virus

CDC experts update on monkeypox in the United States

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome

Study shows how a critical Lassa virus protein drives infection

New data shows the substantial protection offered by third and fourth COVID-19 vaccine doses

Researchers discover new key protection against COVID-19 in saliva

Gonorrhea bacteria may have driven the evolution of gene variants that protect older adults against dementia

What is the optimal alcohol consumption level to minimize health loss?

What is the impact of SARS-CoV-2 variant booster vaccinations?

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News